血清C反应蛋白和肿瘤标志物检测对消化道恶性肿瘤的诊断价值(3)
[参考文献]
[1] 刘淼,顾春瑜,王海滨.血清CRP与肿瘤标志物检测在消化道恶性肿瘤中的临床意义[J].检验医学与临床,2019,16(4):493-495,498.
[2] 晋飞.消化道疾病血清CRP与肿瘤标志物的联合检测意义[J].中西医结合心血管病电子杂志,2016,4(18):132,134.
[3] 曾繁昌,曾繁明.消化道疾病血清CRP与肿瘤标志物的联合检测意义[J].数理医药学杂志,2017,30(2):201-202.
[4] 李再来.血清CRP、IL-6与典型肿瘤标志物检测用于胃癌患者中的临床有效性[J].临床检验杂志:电子版,2017,6(1):105-106.
[5] 宋国伟,李宏.血清与腹水肿瘤标志物检查在腹水良恶性鉴别诊断中的价值观察[J].基层医学论坛,2019(26):3751-3752.
[6] 王莉,赵莹,张辉,等.多种血清肿瘤标志物联合检测诊断非小细胞肺癌的价值分析[J].河北医药,2019(17):2594-2597.
[7] Litman-Zawadzka Ala,ukaszewicz-Zajc Marta,Gryko Mariu sz,et al. Serum chemokine CXCL-8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR-2, CRP and classical tumor markers (CA 19-9 and CEA)[J].Polish archives of internal medicine,2018.
[8] 徐鵬,陈晶,熊秀娥.CT联合血清肿瘤标记物诊断及鉴别诊断卵巢良恶性肿瘤[J].现代肿瘤医学,2019,27(9):1606-1609.
[9] 吴柳.联合检测血清肿瘤标记物在恶性肿瘤诊断中的价值[J].世界最新医学信息文摘,2019,19(19):162.
[10] Kazuyuki Ishida,Mitsumasa Osakabe,Makoto Eizuka,et al. The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location[J]. Human Pathology,2019.
(收稿日期:2019-12-18), 百拇医药(疏东升)
[1] 刘淼,顾春瑜,王海滨.血清CRP与肿瘤标志物检测在消化道恶性肿瘤中的临床意义[J].检验医学与临床,2019,16(4):493-495,498.
[2] 晋飞.消化道疾病血清CRP与肿瘤标志物的联合检测意义[J].中西医结合心血管病电子杂志,2016,4(18):132,134.
[3] 曾繁昌,曾繁明.消化道疾病血清CRP与肿瘤标志物的联合检测意义[J].数理医药学杂志,2017,30(2):201-202.
[4] 李再来.血清CRP、IL-6与典型肿瘤标志物检测用于胃癌患者中的临床有效性[J].临床检验杂志:电子版,2017,6(1):105-106.
[5] 宋国伟,李宏.血清与腹水肿瘤标志物检查在腹水良恶性鉴别诊断中的价值观察[J].基层医学论坛,2019(26):3751-3752.
[6] 王莉,赵莹,张辉,等.多种血清肿瘤标志物联合检测诊断非小细胞肺癌的价值分析[J].河北医药,2019(17):2594-2597.
[7] Litman-Zawadzka Ala,ukaszewicz-Zajc Marta,Gryko Mariu sz,et al. Serum chemokine CXCL-8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR-2, CRP and classical tumor markers (CA 19-9 and CEA)[J].Polish archives of internal medicine,2018.
[8] 徐鵬,陈晶,熊秀娥.CT联合血清肿瘤标记物诊断及鉴别诊断卵巢良恶性肿瘤[J].现代肿瘤医学,2019,27(9):1606-1609.
[9] 吴柳.联合检测血清肿瘤标记物在恶性肿瘤诊断中的价值[J].世界最新医学信息文摘,2019,19(19):162.
[10] Kazuyuki Ishida,Mitsumasa Osakabe,Makoto Eizuka,et al. The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location[J]. Human Pathology,2019.
(收稿日期:2019-12-18), 百拇医药(疏东升)